Drug Discovery Today Reviews

Yale Center for Molecular Discovery

YCMD has conducted comprehensive meta-analyses of FDA-approved drugs published in a series of Drug Discovery Today manuscripts. 

• An analysis of original research contributions toward FDA-approved drugs
• A history of drug development in four acts

• Target selection for FDA-approved medicines

• Post-approval fate of pharmaceutical companies

• An overview of FDA-approved biologics medicines

• An analysis of FDA-approved drugs for oncology

• Trends in pharmaceutical targeting of clinical indications: 1930-2013

• The rise (and decline?) of biotechnology

• An analysis of FDA-approved drugs for infectious disease: HIV/AIDS drugs

• An analysis of FDA-approved drugs for pain and anesthesia

• An analysis of FDA-approved drugs for cardiovascular diseases

• An analysis of FDA-approved drugs for psychiatric disorders

• An analysis of FDA-approved drugs for infectious disease: antibacterial agents

• An overview of FDA-approved new molecular entities: 1827-2013

• An analysis of FDA-approved drugs: natural products and their derivatives

• An analysis of FDA-approved drugs for metabolic diseases

• An analysis of FDA-approved drugs for neurological disorders